Skip to content
Valuesider
Guess what? Valuesider just got better: smarter and more intuitive.
Novartis AG ADR

NVS

Novartis AG ADR

Novartis AG ADR 13F Holders

NVS Stock Ownership Activity

# of activities:
3
AVG reported price*:
$128.24
Current price*:
+20.19%($154.13)
3 value investing gurus have made changes to the Novartis AG ADR (NVS) position according to the gurus' 2025 Q3 SEC quarterly report(s). The number of NVS shares has been decreased by 3 super investor(s).

Which gurus or hedge funds bought NVS in 2025 Q3?

According to the 2025 Q3 SEC filing(s) Novartis AG ADR (NVS) has not been purchased by any super investor.
To see more about who is investing in Novartis AG ADR (NVS), please go to the NVS ownership page.
3 results
History Name Company % or
activity 		Shares
change 		Shares
held after* 		% change
to portfolio 		% of
portfolio 		Held since* Held for*
Sarah Ketterer
Causeway Capital Management
-1.44%
-30
2,054
-0%
0.00%
2013 Q2 or earlier
≈ 12.50+ years
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
-1.57%
-1,215
76,054
-0.01%
0.85%
2013 Q2 or earlier
≈ 12.50+ years
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
-22.44%
-4,145
14,326
-0.11%
0.35%
2013 Q2 or earlier
≈ 12.50+ years
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.